Form 4 for DFTX Definium Therapeutics, Inc.
Accepted 2022-05-26 00:00:00 ET · period of report 2022-05-25 · accession 0001209191-22-032383 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-26 | 2022-05-25 | DFTX | Barrow Robert | CEO, Dir | S - Sale | $0.77 | -18.4K | 3.98M | -0.5% | -$14.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Subordinate Voting Shares | 2022-05-25 | S | D | 18,415 | $0.77 | 3,976,894 | D | — | — | (F2) The Subordinate Voting Shares were sold in one transaction at a price of $0.99 CAD Dollars. This represents the price in United States Dollars using the conversion rate on May 25, 2022. |